Nature Communications, Apr 10, 2025
Future studies are needed and will hopefully replicate our results, involve a larger sample size, have a control arm, and include a longer follow-up with the goal of continuing to improve MGD treatment, enhance patients quality of life, and help relieve some of the long-term healthcare burden related to ocular surface diseases in the United States
A 2023 systematic review by Johnson et al
Pharmacies with higher quality control infrastructure and more rigorous testing charge more, and clinics that source from those pharmacies pass the cost through
Schedule your treatment consultation by phone or online at Naples Regenerative Institute today.
This makes oral delivery the preferred route for GI-specific indications, while injectable delivery is preferred for systemic tissue repair goals (joint, muscle, tendon, systemic inflammation)